
New pharma company raising $3M to reformulate existing drugs for eye diseases
A new ophthalmic drug company hoping to reformulate existing drugs to “bring better drugs, at better prices, to the patient” looks to be getting off the ground with some early capital. Eye-Pharma, founded by a retina surgeon and pharmaceutical executives from the company Ezra Innovations in 2013, disclosed in a new SEC filing that it’s […]